Once-daily RELEXXII® (methylphenidate hydrochloride extended-release tablet) supports Attention Deficit Hyperactivity Disorder (ADHD) Awareness Month

RELEXXIIPositive

AI Analysis

Summary

Vertical Pharmaceuticals highlights RELEXXII (methylphenidate HCl extended-release) during ADHD Awareness Month in October 2026, emphasizing the importance of timely diagnosis and personalized treatment for ADHD patients.

Importance:2/10

Sentiment:

0.30

ADHDawarenesstreatmentprecision dosingonce-daily formulation

Related Companies

$CHCT

Read the original article

Published by PR Newswire Biotech on October 6, 2026 12:08 PM

Read Original